ABT vs. MCK: Abbott Laboratories vs. McKesson Stock Comparison
How do Abbott Laboratories (ABT) and McKesson (MCK) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Abbott Laboratories (ABT) and McKesson (MCK) both fall under the Health Care Equipment & Services industry group, but ABT is classified in Health Care Equipment & Supplies while MCK is classified in Health Care Providers & Services.
| Profile Item | ABT | MCK |
|---|---|---|
| Name | Abbott Laboratories | McKesson Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Equipment | Health Care Distributors |
| Market Capitalization | 173.61 billion USD | 97.04 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | March 17, 1980 | November 10, 1994 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | ABT | MCK |
|---|---|---|
| Total Return (1Y) | -18.04% | 17.01% |
| Total Return (3Y, Annualized) | -2.45% | 26.58% |
| Total Return (5Y, Annualized) | -1.58% | 33.94% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | ABT | MCK |
|---|---|---|
| Volatility (1Y, Annualized) | 26.27% | 30.21% |
| Beta (5Y) | 0.60 | 0.31 |
| Max Drawdown (5Y) | -39.64% | -27.17% |
| Avg. Volume (3M) | 13.53M | 1.18M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | ABT | MCK |
|---|---|---|
| Sharpe Ratio (1Y) | -0.84 | 0.43 |
| Sortino Ratio (1Y) | -1.18 | 0.70 |
Profitability
ROE (TTM)
Neither Abbott Laboratories (ABT) nor McKesson (MCK) reports a ROE value for this period, so a direct comparison isn’t possible.
ABT
Health Care Equipment & Services industry group
--
- Max
- 53.65%
- Q3
- 13.93%
- Median
- 3.71%
- Q1
- -16.92%
- Min
- -59.21%
- ABT
- --
MCK
Health Care Equipment & Services industry group
--
- Max
- 53.65%
- Q3
- 13.93%
- Median
- 3.71%
- Q1
- -16.92%
- Min
- -59.21%
- MCK
- --
Net Margin (TTM)
Abbott Laboratories (ABT) at 11.65% retains a top-quartile share of revenue as profit, ahead of McKesson (MCK) at 1.18%, which keeps about the industry-typical share.
ABT
Health Care Equipment & Services industry group
11.65%
- Max
- 30.40%
- ABT
- 11.65%
- Q3
- 8.56%
- Median
- 1.55%
- Q1
- -9.20%
- Min
- -34.34%
MCK
Health Care Equipment & Services industry group
1.18%
- Max
- 30.40%
- Q3
- 8.56%
- Median
- 1.55%
- MCK
- 1.18%
- Q1
- -9.20%
- Min
- -34.34%
Operating Margin (TTM)
Abbott Laboratories (ABT) at 14.15% operates in the top operating margin quartile, ahead of McKesson (MCK) at 2.21%, which runs around its industry’s norm.
ABT
Health Care Equipment & Services industry group
14.15%
- Max
- 37.54%
- ABT
- 14.15%
- Q3
- 12.86%
- Median
- 5.54%
- Q1
- -4.10%
- Min
- -25.61%
MCK
Health Care Equipment & Services industry group
2.21%
- Max
- 37.54%
- Q3
- 12.86%
- Median
- 5.54%
- MCK
- 2.21%
- Q1
- -4.10%
- Min
- -25.61%
Profitability Metrics
| Metric | ABT | MCK |
|---|---|---|
| ROE (TTM) | -- | -- |
| ROA (TTM) | -- | 4.99% |
| Net Margin (TTM) | 11.65% | 1.18% |
| Operating Margin (TTM) | 14.15% | 2.21% |
| Gross Margin (TTM) | 56.77% | 3.60% |
Growth
Revenue Growth
Both Abbott Laboratories (ABT) at 5.67% and McKesson (MCK) at 12.36% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
McKesson (MCK) at 49.22% sits in the top EPS growth quartile, while Abbott Laboratories (ABT) at -51.31% is in the bottom quartile, showing a clear gap in earnings momentum.
Growth Metrics
| Metric | ABT | MCK |
|---|---|---|
| Revenue Growth (YoY) | 5.67% | 12.36% |
| Revenue Growth (3Y CAGR) | 0.51% | 13.39% |
| EPS Growth (YoY) | -51.31% | 49.22% |
| EPS Growth (3Y CAGR) | -1.65% | 15.31% |
Financial Strength
Current Ratio (MRQ)
Short-term liquidity can only be read on one side of this pairing: McKesson (MCK) shows current ratio of 0.85 against its industry benchmark, while Abbott Laboratories (ABT) has no reading this period.
ABT
Health Care Equipment & Services industry group
--
- Max
- 7.79
- Q3
- 4.32
- Median
- 2.03
- Q1
- 1.34
- Min
- 0.04
- ABT
- --
MCK
Health Care Equipment & Services industry group
0.85
- Max
- 7.79
- Q3
- 4.32
- Median
- 2.03
- Q1
- 1.34
- MCK
- 0.85
- Min
- 0.04
Debt / Equity (MRQ)
Only one side’s leverage can be read here: Abbott Laboratories (ABT) carries debt-to-equity ratio of 0.65 against its industry range, while McKesson (MCK) reports no figure this period.
ABT
Health Care Equipment & Services industry group
0.65
- Max
- 2.02
- Q3
- 0.99
- ABT
- 0.65
- Median
- 0.58
- Q1
- 0.15
- Min
- 0.00
MCK
Health Care Equipment & Services industry group
--
- Max
- 2.02
- Q3
- 0.99
- Median
- 0.58
- Q1
- 0.15
- Min
- 0.00
- MCK
- --
Financial Strength Metrics
| Metric | ABT | MCK |
|---|---|---|
| Current Ratio (MRQ) | -- | 0.85 |
| Debt / Equity (MRQ) | 0.65 | -- |
| Net Debt / EBITDA | 2.26 | 0.70 |
Dividends
Dividend Yield (TTM)
Both Abbott Laboratories (ABT) at 2.44% and McKesson (MCK) at 0.38% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.
ABT
Health Care Equipment & Services industry group
2.44%
- ABT
- 2.44%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
MCK
Health Care Equipment & Services industry group
0.38%
- MCK
- 0.38%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both Abbott Laboratories (ABT) at 78.96% and McKesson (MCK) at 8.26% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.
ABT
Health Care Equipment & Services industry group
78.96%
- ABT
- 78.96%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
MCK
Health Care Equipment & Services industry group
8.26%
- MCK
- 8.26%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | ABT | MCK |
|---|---|---|
| Dividend Yield (TTM) | 2.44% | 0.38% |
| Dividend Payout Ratio (TTM) | 78.96% | 8.26% |
Valuation
P/E Ratio (TTM)
Both Abbott Laboratories (ABT) at 32.89 and McKesson (MCK) at 21.65 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
ABT
Health Care Equipment & Services industry group
32.89
- Max
- 73.47
- Q3
- 45.86
- ABT
- 32.89
- Median
- 30.56
- Q1
- 21.37
- Min
- 0.91
MCK
Health Care Equipment & Services industry group
21.65
- Max
- 73.47
- Q3
- 45.86
- Median
- 30.56
- MCK
- 21.65
- Q1
- 21.37
- Min
- 0.91
P/S Ratio (TTM)
McKesson (MCK) at 0.24 sits in the cheaper P/S ratio quartile while Abbott Laboratories (ABT) at 3.73 prices around its industry’s middle — MCK costs less per dollar of sales, though read it alongside growth and margins.
ABT
Health Care Equipment & Services industry group
3.73
- Max
- 8.58
- Q3
- 4.23
- ABT
- 3.73
- Median
- 2.05
- Q1
- 1.10
- Min
- 0.04
MCK
Health Care Equipment & Services industry group
0.24
- Max
- 8.58
- Q3
- 4.23
- Median
- 2.05
- Q1
- 1.10
- MCK
- 0.24
- Min
- 0.04
P/B Ratio (MRQ)
McKesson (MCK) reports a negative P/B ratio of -45.79, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Abbott Laboratories (ABT) reports 3.33, ranking against industry peers normally.
ABT
Health Care Equipment & Services industry group
3.33
- Max
- 12.13
- Q3
- 5.82
- ABT
- 3.33
- Median
- 2.96
- Q1
- 1.56
- Min
- -2.02
MCK
Health Care Equipment & Services industry group
-45.79
- Max
- 12.13
- Q3
- 5.82
- Median
- 2.96
- Q1
- 1.56
- Min
- -2.02
- MCK
- -45.79
Valuation Metrics
| Metric | ABT | MCK |
|---|---|---|
| P/E Ratio (TTM) | 32.89 | 21.65 |
| P/S Ratio (TTM) | 3.73 | 0.24 |
| P/B Ratio (MRQ) | 3.33 | -45.79 |
| Free Cash Flow Yield (TTM) | -- | 5.83% |